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           An important mechanism used by the adaptive 
immune system to limit eff  ector responses is 
active suppression of immune cells by subsets 
of CD4 T cells, which are generally classifi  ed 
as regulatory T (T reg) cells (  1  ). Among the 
molecules commonly associated with T reg cell 
suppressive activity are the transcription factor 
Foxp3 and the immunosuppressive cytokine 
IL-10. Expression of   Foxp3   is induced in a sub-
set of CD4 T cells generated during thymic 
diff  erentiation, which are commonly referred 
to as natural T reg cells but can also be induced 
extrathymically to produce so-called adaptive 
or induced T reg cells (  2  ). It is now clear that, 
at a minimum, Foxp3 is essential for amplifying 
and sustaining a transcriptional program that is 
essential for T reg cell function (  3  ). 
  IL-10 is expressed by numerous hematopoi-
etic cells, including CD4 T cells, and is typically 
linked to immunosuppression (  4  ). Elevated ex-
pression of IL-10 has been used as a defi  ning 
feature of a subset of T reg cells referred to as 
T reg type 1 (Tr1), which do not express Foxp3 
(  5, 6  ). However, on a population level,   Il10   is 
one of the genes expressed by Foxp3  +   T reg cells 
and is thus part of the T reg cell transcriptional 
signature (  7  ). Yet in the steady-state in mice, only 
in intestinal tissues are the majority of Foxp3-
  expressing cells competent to coexpress IL-10 (  8  ). 
Moreover, the intestines, as well as all peripheral 
lymphoid tissues, harbor CD4  +  Foxp3        cells that 
are competent for IL-10 expression and do not 
express eff  ector cytokines, which is consistent 
with a Tr1 phenotype (  8, 9  ). Additionally, IL-
10  –    expressing cells develop in association with 
every eff  ector CD4 T cell subset yet described, 
apparently as an intrinsic Foxp3-independent 
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  Extrathymic induction of regulatory T (T reg) cells is essential to the regulation of effector 
T cell responses in the periphery. In addition to Foxp3, T reg cell expression of suppressive 
cytokines, such as IL-10, is essential for peripheral tolerance, particularly in the intestines. 
TGF-     has been shown to induce expression of   Foxp3   as well as   IL10   and the vitamin A 
metabolite; all-trans retinoic acid (RA [at-RA]) has been found to enhance the former. We 
report that in contrast to its enhancement of TGF-      –  mediated   Foxp3   induction, at-RA 
potently inhibits the TGF-      –  mediated induction of   Il10   in naive CD4 T cells. Thus, mucosal 
DC subsets that are active producers of at-RA inhibit induction of   Il10   in naive CD4 T cells 
while promoting induction of   Foxp3  . Accordingly, mice with vitamin A defi  ciency have 
increased numbers of IL-10  –  competent T reg cells. Activation of DCs by certain Toll-like 
receptors (TLRs), particularly TLR9, suppresses T cell induction of   Foxp3   and enables induc-
tion of   Il10  . Collectively, our data indicate that at-RA has reciprocal effects on the induc-
tion of   Foxp3   and   Il10   in developing CD4  +   T reg cells and suggest that TLR9-dependent 
inhibition of at-RA production by antigen-presenting cells might represent one mechanism 
to promote the development of IL-10  –  expressing T cells. 
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rendered them capable of inducing   Il10   while limiting their 
induction of Foxp3 through combined induction of IL-6 and 
inhibition of synthesis and/or secretion of at-RA. Interest-
ingly, the CD103        subset of MLN DC, which has been 
shown to be less permissive to   Foxp3   induction (  19  ), also 
inhibited   Il10   induction in an at-RA  –  dependent manner. 
Collectively, our data demonstrate diff  erential eff  ects of 
at-RA on the induction of   Foxp3   and   Il10   in naive CD4 
T cells, and they indicate that TLR ligands can regulate the 
reciprocal expression of these genes both by promoting pro-
infl   ammatory cytokine production and possibly inhibiting 
production of ligands that activate the RAR. 
    RESULTS   
  CpG-activated DCs promote the differentiation 
of   Il10  -expressing T cells 
  The ability of DCs activated by distinct pathogen-associated 
molecular patterns to induce expression of   Foxp3   and/or 
  Il10   in antigen-activated naive T cells was examined. BM-
derived DCs (BMDCs) were activated overnight with the 
TLR ligands lipoteichoic acid (LTA), poly I:C, LPS or CpG 
(CpG oligodeoxynucleotide), or the nucleotide oligomeriza-
tion domain (NOD) 2 agonist muramyl dipeptide (MDP) 
before use as APCs in cocultures with CD4 T cells (Fig. S1 
A, available at http://www.jem.org/cgi/content/full/jem
.20080950/DC1). CD4 T cells were isolated from OT-II 
TCR transgenic mice that had been crossed with the previ-
ously described 10BiT (  Il10.Thy1.1   BAC-In Transgenic) (  8  ) 
and   Foxp3    gfp   (  27  ) dual-reporter mice (10BiT.  Foxp3    gfp  .OT-II; 
[reference   8  ]). These mice harbor two reporter transgenes: 
one in which Thy1.1 (CD90.1) is under the control of the 
mouse   Il10   promoter, and the other in which the gene en-
coding   GFP   has been knocked into the   Foxp3   gene and is 
expressed as a fusion protein. Notably, the Thy1.1 reporter 
controlled by the 10BiT transgene rapidly identifi  es all cells 
that have activated   Il10   gene transcription with high fi  delity 
and sensitivity (  8  ), including cells with active IL-10 produc-
tion from endogenous   Il10   alleles as well as those poised for 
IL-10 production that is restrained by a posttranscriptional 
block on translation of   Il10   transcripts (unpublished data) 
(  8  ). The presence of both reporter transgenes has no adverse 
eff  ects on the expression of either transgene when compared 
with singly transgenic mice, nor does either transgene per-
turb normal levels of IL-10 or Foxp3 (unpublished data) 
(  8, 27  ). As such, these mice have been used previously to iso-
late polyclonal T reg cell subsets defi  ned by coordinate or dif-
ferential expression of   Il10   and   Foxp3   that develop in vivo in 
the steady state (  8  ). In the present study, TCR transgenic cells 
from dual-reporter mice are used to track antigen-specifi  c 
induction of both   IL10   and   Foxp3   by detection of Thy1.1 
and GFP, respectively. For all experiments, isolated CD4 T 
cells were sorted to enrich the naive CD44  lo  GFP       Thy1.1        
fraction before stimulation (Fig. S1 B). 
  There was no appreciable induction of GFP (Foxp3) in T 
cells activated by any of the BMDC populations and only a 
modest, but reproducible, induction of Thy1.1 (  Il10  ) in CD4 
  mechanism of eff  ector T cell regulation (  10  –  13  ). Thus, although 
CD4 T cells with regulatory function can coexpress Foxp3 and 
IL-10, the expression of these two molecules is not always linked, 
and IL-10 represents a cytokine whose expression appears to be 
universal among subsets of both regulatory and eff  ector CD4 T 
cell lineages (  4, 14  ). 
  TGF-     is important for the peripheral induction of both 
  Foxp3   and   Il10   (  15, 16  ). Recently, the vitamin A metabolite 
all-trans retinoic acid (RA [at-RA]) has been shown to be a 
cofactor that enhances TGF-      –  mediated induction of   Foxp3   
(  17  –  20  ). However, a possible role for RA in the TGF-      –
  mediated induction of IL-10 has not been explored. Based on 
the elevated production of at-RA by mucosal DCs (  21  ), it is 
reasonable that at-RA might also participate in the diff  erenti-
ation of IL-10  –  producing T reg cells that are enriched in the 
intestines. Indeed, the   Il10   locus is known to harbor at least 
one RA-responsive element (  22  ). However, it has also been 
reported that the absence of dietary vitamin A enhances the 
development of IL-10  –  producing Th2 cells while reducing 
Th1 development (  23  ), raising the possibility that at-RA 
might, in fact, down-regulate transcription of   Il10  . Further-
more, induction of IL-10 has been linked to the develop-
ment of Th17 cells (  13, 24  ) which is antagonized by RA (  17  ). 
Because RA receptor (RAR) agonists are under consider-
ation as promising therapeutic agents in oral tolerance induc-
tion, it is critical to understand the eff  ects of this signaling 
pathway on regulation of IL-10, a nonredundant regulator of 
gut immunity. 
  In addition to IL-10, the role of Toll-like receptor (TLR) 
pathways in limiting deleterious responses to the commensal 
fl  ora has been established. Mice with a targeted deletion of 
the   Il10   gene develop spontaneous colitis, but mice that are 
doubly defi  cient for   Il10   and the gene encoding MyD88, 
which is essential for most TLR signaling, do not (  25  ). Addi-
tionally, mice in which IL-10 defi  ciency is restricted to CD4 
T cells also develop colitis resembling that seen in complete 
IL-10 defi  ciency (  26  ). Thus, T cell  –  derived IL-10 is essential 
to quell unwanted TLR-dependent responses to commensal 
antigens. We and others have shown that TGF-     can medi-
ate the induction of IL-10 in CD4 T cells both in vitro and 
in vivo (  8, 16  ), but it is unknown whether TLR-dependent 
activation of the innate immune system can contribute to this 
inductive pathway. 
  In a study originally designed to examine whether condi-
tioning of APCs by TLR activation enhanced their ability 
to promote expression of   Il10   in naive CD4 T cells, we ob-
served that in the presence of TGF-    , CpG prestimulation 
rendered DCs potent inducers of   Il10  . Our eff  orts to eluci-
date the mechanism whereby this occurs revealed that in 
contrast to its ability to enhance TGF-      –  mediated induction 
of Foxp3, at-RA potently inhibits the induction of   Il10   tran-
scription in CD4 T cells while having no detectable eff  ects 
on posttranscriptional regulation of   Il10  . Thus, splenic, but 
not mesenteric LN (MLN) and intestinal lamina propria DC, 
supported the TGF-      –  mediated induction of   Il10   in CD4 
T cells. However, prestimulation of MLN DC with CpG JEM VOL. 206, February 16, 2009 
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similarly activated in the lower chamber. After 4 d, each 
group of responder T cells had undergone cell division. 
However, when Thy1.1  +   T cells were placed in the upper 
chamber, the proliferation of responder cells was signifi  cantly 
reduced, and this suppression was reversed in the presence of 
an IL-10 receptor-blocking antibody (  Fig. 1 D  ). These data, 
coupled with the lack of signifi   cant expression of Foxp3 
(  Fig. 1 A  ) or eff  ector cytokines (  Fig. 1 B  ), suggest that the 
combination of CpG-BMDC and TGF-     induce a T cell 
population with characteristics of Tr1 cells. 
  Induction of   Il10   by CpG-activated BMDCs is dependent 
on MyD88 signaling but independent of inducible 
costimulator (ICOS)  –  ICOS ligand (ICOSL) interactions 
  Activation of TLR9 induces a signaling cascade that requires 
the adaptor molecule MyD88. In addition, it has been re-
ported that maturation of plasmacytoid DC with the TLR9 
agonist induces stable expression of the ligand for the ICOS 
(ICOSL), which can then promote the diff  erentiation of IL-
10  –  expressing Tr1-like cells (  34  ). In the presence of BMDCs 
defi  cient for MyD88, CpG-mediated induction of Thy1.1 
was inhibited, whereas GFP expression was increased, most 
likely as a result of diminished production of cytokines such 
as IL-6 which inhibit the induction of Foxp3 (  30  ) (  Fig. 2 A  ).   
Therefore, in this system, the IL-10  –  inducing eff  ect  of 
the CpG stimulation is a result of MyD88-dependent TLR 
signaling in BMDCs and, importantly, not a result of stimula-
tion of the CD4 T cells by residual CpG. However, in the 
presence of BMDCs defi  cient in ICOSL, the frequency of 
Thy1.1, as well as GFP, resembled that observed with WT 
CpG-activated BMDC in the presence of TGF-     only (  Fig. 
2 A  ), indicating that ICOS signaling is dispensable for the 
induction of   Il10   under these conditions. 
  Induction of   Il10   by CpG-activated BMDCs is IL-6 and IL-21 
dependent but IL-27 independent 
  Activation of DCs via TLR9 culminates in the expression of 
numerous cytokines, including type 1 IFNs. In addition, 
studies have shown that IL-12 can induce expression of IL-10 
in developing Th1 cells and, more recently, that IL-27 can 
induce expression of IL-10 in eff  ector T cells (  13, 35, 36  ). It 
was also reported that TGF-     and IL-6 inhibit, whereas IL-
23 enhances, the pathogenic potential of Th17 cells and that 
the reduced pathogenicity can be reversed by IL-10 receptor 
blockade (  24  ). Accordingly, we interrogated the possible 
roles of type 1 IFNs, IL-12, and IL-27 in the CpG-mediated 
induction of   Il10   as well as the ability of IL-23 to inhibit this 
process. The addition of blocking antibodies to the IFN-    /     
receptor (IFN-    /    R1) or to the p40 subunit of IL-12, 
IL-27, or recombinant IL-23 did not signifi  cantly diminish 
expression of Thy1.1 (  Fig. 2 B  ). Thus, the CpG-mediated 
induction of   Il10   is independent of type 1 IFNs, IL-12, and 
IL-27 and is not blocked by the addition of IL-23. 
  In the presence of TGF-    , IL-6 promotes the expression 
of IL-17 in T cells (  13, 24  ). We therefore examined the pos-
sible contribution of IL-6 to the CpG-mediated induction of 
T cells stimulated with CpG-activated BMDC (  Fig. 1 A  , 
top).   However, in the presence of exogenous TGF-    , unac-
tivated, MDP-activated, and Poly I:C-activated BMDCs 
induced expression of GFP by a substantial fraction of T cells 
(22, 24, and 12%, respectively) without appreciable induc-
tion of Thy1.1 (  Fig. 1 A  , bottom). In contrast, LTA- and 
LPS-activated BMDCs induced a more limited fraction of 
GFP (Foxp3)  +   cells (8.5 and 4.7%, respectively) but also 
induced an appreciable fraction of Thy1.1 (  Il10  )  +   cells (4.0 
and 5.6%, respectively). Interestingly, CpG-activated BMDCs 
promoted expression of Thy1.1 by a signifi  cantly higher frac-
tion of CD4 T cells (  >  25%) with limited induction of GFP 
(  <  4%). Notably, GFP and Thy1.1 tended toward diff  erential 
expression by separate fractions of T cells, although a small 
fraction of cells that expressed both was observed under some 
conditions. Collectively, these results indicate that activation 
of DCs by distinct TLR/NOD ligands promotes diff  erential 
expression of Foxp3 and IL-10 by naive T cells stimulated in 
the presence of TGF-    , with extremes of expression induced 
by unactivated DCs or DCs activated via TLR9. Thus, CpG-
activated DCs promote preferential induction of IL-10 rela-
tive to Foxp3. 
  Considering the established role of TGF-     in promoting 
Th17 development, particularly in the presence of certain 
proinfl  ammatory cytokines (  28  –  30  ), we examined the Thy1.1-
expressing T cells for the expression of IL-17. Importantly, 
we saw very little expression of IL-17 by CD4 T cells acti-
vated with CpG-BMDC in the presence of TGF-    , even 
when blocking antibodies against IFN-     and IL-4 were in-
cluded (  Fig. 1 B  ). In fact, the majority of IL-17  +   cells were 
negative for the Thy1.1 reporter molecule. Moreover, we 
observed little or no production of IFN-     or IL-4, suggesting 
that the IL-10  –  expressing cells were distinct from defi  ned 
lineages of eff  ector CD4 T cells. 
  Although we observed relatively modest expression of 
intracellular IL-10 after 5 h of restimulation with PMA and 
ionomycin (unpublished data), messenger RNA (mRNA) 
analysis indicated that   Il10   transcripts were comparably in-
duced in CpG-BMDC  –  activated T cells isolated from both 
WT and reporter transgenic mice, and, as refl  ected in en-
hanced Thy1.1 reporter expression,   Il10   mRNA levels were 
substantially increased by the addition of TGF-     (  Fig. 1 A   
and Fig. S2, available at http://www.jem.org/cgi/content/
full/jem.20080950/DC1). Accordingly, antigenic restimula-
tion of TGF-     plus CpG-BMDC  –  induced Thy1.1  +   T cells 
for 24 h resulted in the accumulation of IL-10 protein in cul-
ture supernatants (  Fig. 1 C  ). This is consistent with previous 
reports that have demonstrated discordance of kinetics of 
induction of   Il10   transcript and protein after activation as a 
result of posttranscriptional regulation of   Il10   expression (  31  –
  33  ). As previously reported (  8  ), sorted Thy1.1        cells failed to 
produce IL-10. To test the functional activity of Thy1.1  +   T 
cells induced in the presence of CpG-BMDCs and TGF-    , 
induced Thy1.1  +   T cells were stimulated with   Il10  -defi  cient 
splenic DCs plus antigen in the upper chamber of a transwell 
system, and CFSE-labeled naive responder T cells were 346 DIFFERENTIAL REGULATION OF FOXP3 AND IL-10 BY RETINOIC ACID   | Maynard et al. 
    Figure 1.         The combination of TGF-        –     and CpG-activated BMDC induces IL-10  –  expressing CD4 T cells  . (A) 10  5   D10 BMDC that were either 
left unactivated or preactivated with the indicated agonists were used in combination with 1   μ  g/ml OVA peptide to stimulate 5   ×   10 5   naive CD4 T cells 
from 10BiT.  Foxp3  gfp  .OT-II mice, in the absence (top) or presence (bottom) of 5 ng/ml of recombinant human TGF-    1. On day 3, CD4 T cells were examined 
for expression of Thy1.1 and GFP. Numbers represent the percentage of CD4 T cells in the respective quadrants. (B) Naive CD4 T cells were stimulated as 
described in A with CpG-BMDC in the presence of TGF-     only or TGF-     plus  anti – IFN-    and anti  –  IL-4 (each at a fi  nal concentration of 10   μ  g/ml). On 
day 5, cells were restimulated for 5 h with PMA/ionomycin in the presence of brefeldin A, and viable CD4 T cells were analyzed for expression of Thy1.1, 
Foxp3, IL-17A, and IFN-    . (C) Day-5 Thy1.1  +   T cells (induced in the presence of CpG-BMDC and TGF-    ) were MACS sorted and cultured for 24 h with 
  Il10     /     splenic DC in the absence (    ) or presence (+) of 1   μ  g/ml OVA peptide. IL-10 protein in culture supernatants was quantitated by cytometric bead 
array. Mean cytokine concentrations   ±  SEM are shown. (ND, not detected). (D) 5   ×   10  5   CFSE-labeled OT-II CD4 T cells were stimulated with 1.0   μ  g/ml OVA 
peptide and 10  5   IL-10 – defi  cient splenic DC in the lower chamber of a transwell plate. In some cases, an equal number of DC or DC plus 5   ×   10  5   day-5 
Thy1.1  +   T cells (differentiated as in C) were similarly activated in the upper chamber. Where indicated, anti  –  IL-10R antibody was added to the lower JEM VOL. 206, February 16, 2009 
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a signifi  cant fraction of intestinal T cells express Foxp3 and/or 
IL-10, we reasoned that perhaps at-RA also contributed to the 
observed induction of   Il10   but that (CpG-induced) IL-6 actively 
inhibited the induction of Foxp3 under these conditions. There-
fore, we examined a possible role for at-RA in the TGF-      –
  mediated induction of IL-10 in the presence of CpG-BMDC. 
Surprisingly, the addition of at-RA in the presence of TGF-    , 
although resulting in increased expression of GFP and CCR9, 
completely suppressed the induction of Thy1.1 (  Fig. 3 B   and 
not depicted). 
  In view of this, we next examined whether the presence of 
at-RA could account for the inability of BMDC stimulated 
with other agonists to induce expression of IL-10. Naive T 
cells were stimulated with unactivated BMDCs or BMDCs 
activated with the various agonists in the absence or presence 
of TGF-     plus at-RA or the RAR inhibitor (RARi) LE540, 
which inhibits RAR-mediated transcriptional activation. In 
accordance with previous reports (  17  –  20  ), addition of at-RA 
increased the frequency of GFP  +   cells, whereas inhibition of 
at-RA completely inhibited induction of GFP under all condi-
tions examined (  Fig. 3 C  , rows 3 and 4, respectively), suggest-
ing that at-RA does not just enhance but is absolutely required 
for TGF-      –  mediated induction of Foxp3. Moreover, because 
the precursor population in all experiments was FACS-sorted 
CD44  lo   naive T cells, the eff  ect of RA was not a result of sup-
pression of the activity of CD44  hi   memory cells as was recently 
suggested (  38  ). In contrast, inhibition of RA signaling by 
LE540 resulted in potent induction of Thy1.1 expression in 
40  –  60% of all T cells, irrespective of the activation state of the 
BMDC or the agonist used for preactivation (  Fig. 3 C  , fourth 
row). In addition, consistent with previous fi  ndings (  17  ), inhi-
bition of RAR in the presence of TGF-     resulted in enhanced 
expression of IL-17A (  Fig. 3 C  , bottom), which correlated 
with the levels of IL-6 produced by the respective BMDC 
subsets. Importantly, in the presence of unactivated BMDCs 
whose IL-6 output was just at the limit of detection (20 pg/ml; 
  Fig. 2 C  , left), there was minimal induction of IL-17 (  Fig. 3 C  , 
bottom), demonstrating that induction of   Il10   in the absence 
of RAR signaling is not merely a byproduct of Th17 diff  eren-
tiation. Accordingly, in an APC-free system with the RAR 
antagonist and a low dose of IL-6 (100 pg/ml), we observed 
induction of   Il10   but minimal expression of IL-17 despite 
increasing doses of TGF-     (Fig. S3, top, available at http://
www.jem.org/cgi/content/full/jem.20080950/DC1). How-
ever, at a 100-fold higher dose of IL-6, induction of both   Il10   
and IL-17 was observed, both of which increased with increas-
ing doses of TGF-     (Fig. S3, bottom). Thus, in the absence of 
at-RA signaling, TGF-     favors induction of   Il10   in the pres-
ence of low doses of IL-6, whereas IL-17 is induced by higher 
doses of IL-6. 
  We then quantifi  ed the IL-10 protein output of CD4 
T cells stimulated with the various BMDC subsets in the 
Thy1.1 by stimulating naive T cells with CpG-activated 
BMDC in the presence of TGF-     and an IL-6  –  neutralizing 
antibody (  Fig. 2 B  , bottom). Neutralization of IL-6 inhibited 
the induction of Thy1.1 and, as expected, promoted increased 
expression of GFP. There was a similar inhibition of Thy1.1 
induction by IL-21 neutralization, suggesting that, similar to 
TGF-      –  mediated induction of IL-17, CpG-BMDC and 
TGF-     cooperatively induce   Il10   via a mechanism that is 
dependent on IL-6 and IL-21. 
  Given the critical roles for IL-6 and IL-21 in the CpG-
mediated induction of IL-10, we examined whether expres-
sion of these two cytokines was a distinguishing feature of 
CpG-activated BMDCs compared with BMDCs activated 
with other TLR/NOD ligands. BMDCs were stimulated 
with the previous panel of pathogen-associated molecular 
patterns, and the production of IL-6 and IL-21 was quanti-
tated. As expected, CpG-activated BMDCs produced a sub-
stantial quantity of IL-6 (17.5   ±   0.4 ng/ml) compared with 
unactivated D10 BMDC (  Fig. 2 C  , left). However, LPS-
  activated BMDCs produced more than twice as much IL-6 as 
their CpG-stimulated counterparts (38.2   ±   1.3 ng/ml). BM-
DCs activated with LTA and poly I:C also produced readily 
detectable quantities of IL-6 (4.1   ±   0.2 and 2.1   ±   0.1 ng/ml, 
respectively), albeit substantially less than those of CpG- and 
LPS-BMDCs. Interestingly, sorted CpG-induced Thy1.1  +   
cells produced limited amounts of IL-6 upon restimulation 
(0.6   ±   0.0 ng/ml). All BMDC populations were negative for 
IL-21 (unpublished data). However, upon antigenic restimu-
lation, sorted Thy1.1  +   cells induced in the presence of CpG-
BMDC produced a signifi  cant amount of IL-21 (1.3   ±   0.1 
ng/ml), suggesting that T cell  –  derived IL-21 functions in an 
autocrine manner to induce T cell expression of   Il10   (  Fig. 2 C  , 
right). Collectively, these data establish a parallel between 
induction of   Il10   and   Il17   in CD4 T cells, where IL-6 in-
duces early expression of IL-21, which then functions in an 
autocrine manner to promote   Il10   gene expression. How-
ever, the elevated levels of IL-6 produced by other activated 
BMDCs, particularly LPS-activated BMDCs, suggested that 
IL-6, and/or the subsequent induction of IL-21, could not 
solely account for the diff  erential induction of   Il10   by CpG-
activated BMDCs in comparison to unactivated BMDCs or 
BMDCs activated with other TLR/NOD agonists. 
  RA inhibits the induction of   Il10   in CD4 T cells 
  Our group and others have previously demonstrated substan-
tial enrichment of IL-10  –  expressing T cells in intestinal tissues 
(  8, 9, 37  ). Examination of the CpG-BMDC  –  induced Thy1.1-
expressing cells revealed elevated expression of the gut-homing 
receptors     4    7 and CD103 but, importantly, not CCR9 
(  Fig. 3 A  ).   Expression of CCR9 can be induced by at-RA (  21  ), 
which also enhances TGF-      –  mediated induction of Foxp3-
expressing T reg cells from naive precursors. Considering that 
chamber at a fi  nal concentration of 10   μ  g/ml. After 4 d, cells were harvested from the bottom chamber and the CFSE profi  le of the CD4 T cells was ana-
lyzed by FACS. Numbers in A and B indicate the percentages of CD4 T cells in the given quadrants. All data are representative of at least two experiments.     
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ulation of IL-6 production, is likely a result of its inhibition 
of production of RAR ligands such as at-RA by DCs. 
  RA principally inhibits transcription but not translation 
of   Il10   
  Having established the critical roles of IL-6 and IL-21 in the 
induction of   Il10   in response to TGF-     and CpG-BMDC 
stimulation, we next examined whether the ability of at-RA 
to suppress   Il10   induction involved repression of these two 
cytokines. The production of IL-6 and IL-21 by CD4 T cells 
stimulated with the various BMDC populations in the pres-
ence of TGF-    , TGF-     plus at-RA, and TGF-     plus RARi 
was determined. We found that IL-6 was induced under all 
conditions examined and that the production was not signifi  -
cantly aff  ected by the addition of at-RA or blockade of RAR 
signaling (  Fig. 4 A  ), indicating that the mechanism of at-RA 
suppression of   Il10   did not involve suppression of IL-6.   
Notably, CD4 T cells stimulated with CpG-BMDC and 
TGF-    , which contained the largest fraction of Thy1.1  +   
cells, produced signifi  cantly higher levels of IL-6, which is 
suggestive of a role for autocrine IL-6 in amplifying the in-
duction of   Il10   in CD4 T cells. In contrast, IL-21, which was 
also produced by all polarized T cell subsets, was signifi  cantly 
down-regulated by the addition of at-RA and rebounded in 
the presence of RARi, except in the CpG-BMDC  –  induced 
T cells (  Fig. 4 B  ). Collectively, these data indicate that despite 
the demonstrated involvement of IL-6 and IL-21 in the 
CpG-mediated induction of IL-10, the ability of at-RA to 
inhibit this induction is independent of these two cytokines. 
  We next examined the specifi  c eff  ect of at-RA on   Il10   
mRNA induction in the presence of CpG-BMDC and 
TGF-     (  Fig. 4 C  ). Naive T cells were stimulated using CpG-
BMDC in the presence of TGF-     only, TGF-     plus at-RA, 
or TGF-     plus RARi, and   Il10   transcript levels were mea-
sured relative to cells activated by the same BMDC popula-
tion in the absence of TGF-    . In accord with previous data 
examining Thy1.1 reporter expression, stimulation in the 
presence of TGF-     induced up-regulation of   Il10   mRNA 
transcripts, whereas the addition of at-RA resulted in reduced 
  Il10   transcript levels. Importantly, RAR blockade allowed 
for increased   Il10   mRNA expression above that induced by 
addition of TGF-     alone, suggesting that although CpG 
treatment of DCs likely suppresses production of RAR 
ligands to promote   Il10   induction, this is incomplete. 
  Because the Thy1.1 reporter transcript generated by 
activation of the   Il10   gene in the 10BiT transgene utilizes an 
exogenous 3     untranslated region that lacks the degradation 
signals present in the native   Il10   3     untranslated region (  8  ), 
the observed profound blockade of both transgenic reporter 
and endogenous   Il10   transcripts by at-RA suggested inhibi-
tion primarily at the level of conversion of the   Il10   gene to a 
transcriptionally poised state and not mRNA stability (  Fig. 3 
C, Fig. 4 C,   and not depicted). Given the substantial post-
transcriptional regulation of   Il10  , however, we further exam-
ined whether at-RA inhibited production of IL-10 protein 
by cells already activated to express   Il10  . To this end, we 
presence of TGF-    , TGF-     plus at-RA, and TGF-     plus 
RARi (  Fig. 3 D  ). Consistent with the elevated expression of 
the Thy1.1 reporter molecule, T cells activated in the pres-
ence of CpG-BMDC and TGF-     produced signifi  cantly 
higher amounts of IL-10 relative to other conditions. Fur-
thermore, the addition of at-RA in the presence of TGF-     
suppressed the production of IL-10 to near baseline levels. In 
contrast, RAR blockade in the presence of TGF-     resulted 
in a signifi  cant increase in IL-10 production by T cells acti-
vated by all BMDC populations in the presence of TGF-    . 
Collectively, these data establish that at-RA potently blocks 
induction of   Il10   and suggest that an important eff  ect of CpG 
in promoting T cell induction of   Il10  , in addition to its stim-
    Figure 2.         CpG-BMDC  –  mediated induction of IL-10 in CD4 T cells 
is Myd88 and ICOSL independent but IL-6 and IL-21 dependent.  
(A) Naive T cells were activated on CpG-BMDC from WT,   Myd88     /   ,  or 
  Icosl     /     mice in the presence of TGF-     and analyzed on day 3 for expres-
sion of Thy1.1 and GFP. (B) CD4 T cells were cultured with WT CpG-BMDC 
plus TGF-     in the presence of the additives indicated and analyzed on 
day 3 for expression of Thy1.1 and GFP. (C) D10 BMDC (left) were left 
unstimulated or stimulated for 24 h with the indicated TLR/NOD agonists. 
MACS purifi  ed CD4  + Thy1.1 +   cells (right), induced in the presence of CpG-
BMDC plus TGF-    , were cultured for 24 h with   Il10     /     splenic DC in the 
absence or presence of OVA peptide. IL-6 was quantifi  ed by cytometric 
bead array and IL-21 by ELISA. Mean cytokine concentrations   ±  SEM are 
shown (ND, not detected; *, P   <   0.05; ***, P   <   0.001). All data are represen-
tative of at least three experiments.     JEM VOL. 206, February 16, 2009 
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sorted CD4  +  Thy1.1  +   cells from 10BiT mice (  Fig. 4 D  , top) 
and restimulated with anti-CD3 and anti-CD28 antibodies 
for 24 h before quantifying the IL-10 protein content of the 
culture supernatants.   Il10  -competent CD4 T cells stimulated 
ex vivo produced a substantial amount of IL-10 protein 
(1.7   ±   0.1 ng/ml) (  Fig. 4 D  ). Although stimulation in the pres-
ence of at-RA showed modest reduction of IL-10 produc-
tion, this did not achieve statistical signifi  cance. Accordingly, 
restimulation in the presence of the RARi did not aff  ect 
production relative to cells restimulated in the absence of 
any additives (1.8   ±   0.1 ng/ml). Therefore, although at-RA 
inhibits induction of transcription of   Il10   by naive CD4 T 
cells stimulated in the presence of TGF-    , it does not impede 
the production of IL-10 by cells already committed to ex-
pression of   Il10  , indicating principal eff  ects at the level of 
transcription and not translation. 
  RA produced by mucosal DCs inhibits TGF-      –  mediated 
induction of   Il10   
  Mucosal but not splenic DCs are known to possess the enzy-
matic machinery required to convert vitamin A to at-RA and 
have thus been shown to promote expression of Foxp3 and 
gut-homing receptors in T cells (  21, 39  ). Therefore, we puri-
fi  ed total CD11c  +   DCs from the spleen, MLN, small intes-
tine lamina propria (sLP), and colon lamina propria (cLP) 
and compared their abilities to induce IL-10 and/or Foxp3 
reporter expression in naive CD4 T cells. In response to anti-
genic stimulation only, none of the DC subsets induced 
signifi  cant levels of the   Il10   reporter (  Fig. 5 A  , top)  . How-
ever, in the presence of TGF-    , splenic DCs induced low-
level expression of GFP and readily detectable levels of 
Thy1.1 (3.2 and 8% of CD4 T cells, respectively). In con-
trast, MLN, sLP, and cLP DC failed to induce Thy1.1 ex-
pression but, as expected, induced a signifi  cant population of 
GFP-expressing cells (21, 17, and 8.5% of CD4 T cells, re-
spectively;   Fig. 5 A  , bottom). Similar to what was observed 
with the CpG-BMDC  –  stimulated T cells, the addition of 
at-RA resulted in an increase in GFP  +   cells in the presence 
of both splenic and MLN DCs (39 and 49%, respectively) but 
completely inhibited the induction of Thy1.1 in the presence 
of splenic DCs and TGF-     (  Fig. 5 B  ). Interestingly, in the 
presence of TGF-     and the RA inhibitor, both splenic and 
MLN DCs induced a signifi  cant fraction of Thy1.1- expressing 
cells (27 and 23%, respectively) and a reduced percentage of 
GFP-expressing cells (0.8 and 1.7%, respectively). In addi-
tion, prestimulation of splenic and MLN DCs with CpG also 
resulted in increased Thy1.1 (47 and 19%, respectively) and 
reduced GFP expression (6.0 and 5.6%, respectively). Col-
lectively, these data indicate that, similar to BMDCs, MLN 
DC-derived at-RA inhibits the induction of Thy1.1 (hence 
IL-10) while favoring Foxp3 induction. 
  Elevated expression of at-RA and the consequent ability 
to induce expression of Foxp3 has been associated with the 
CD103  +   subset of mucosal DCs (  20, 40  ). Induction of Foxp3 
and the corresponding inhibition of IL-10 induction appear 
to correlate with an enrichment of CD103  +   DCs within the 
total DC population isolated from MLN as well as sLP and 
cLP (21, 37, and 31%, respectively). In contrast, splenic DCs, 
which are essentially devoid of this subset, were permissive to 
induction of IL-10 (Fig. S4 A, available at http://www.jem
.org/cgi/content/full/jem.20080950/DC1). To address spe-
cifi  c inductive roles of DCs divided on the basis of CD103, 
we sorted MLN DCs into CD103        and CD103  +   fractions 
(Fig. S4 B) and examined their respective abilities to induce 
  Il10   expression. Consistent with published reports, both 
CD103        and CD103  +   MLN DC induced expression of GFP 
(17 and 53% of CD4 T cells, respectively) when stimulated in 
the presence of TGF-    . However, under the same condi-
tions, both DC subsets induced minimal levels of Thy1.1 (2.4 
and 0.9% of CD4 T cells, respectively;   Fig. 5 C  ). The induc-
tion of GFP and the minimal induction of Thy1.1 suggest 
that the at-RA production by CD103        DC is suffi   cient to 
inhibit induction of IL-10 and demonstrate that expression of 
CD103 does not absolutely correlate with a diff  erential ca-
pacity of mucosal DCs to mediate induction of   Foxp3   or   Il10  . 
Accordingly, inclusion of an RARi in the cultures of CD103        
MLN DCs almost completely inhibited induction of GFP 
(1.2% of CD4 T cells) and allowed for the robust induction 
of Thy1.1 (26% of CD4 T cells;   Fig. 5 C  ). Although the 
RARi also greatly blocked GFP induction by CD103  +   DCs 
(  >  75% inhibition), GFP expression was incompletely extin-
guished, apparently as a result of incomplete inhibition of 
RAR by RARi at the high levels of at-RA generated by this 
DC population (  Fig. 5 C   and not depicted). Similarly, addi-
tion of the RARi promoted a more modest induction of 
Thy1.1 by CD103  +   DCs. Collectively, these data demon-
strate that mucosal DCs promote induction of   Foxp3   and 
inhibit induction of   Il10   via an RA  –  dependent mechanism. 
  Reciprocal effects on expression of   Il10   and   Foxp3   
by dietary modulation of vitamin A 
  Given the potency of mucosal DC-derived at-RA at sup-
pressing induction of   Il10   in vitro, we examined the eff  ects of 
modulation of the dietary RA precursor vitamin A on devel-
opment of T reg cell subsets in vivo. 10BiT.  Foxp3    gfp   mice 
were placed on diets with normal (vitamin A control [VAC]), 
defi  cient (vitamin A defi  cient [VAD]), or high (vitamin A 
high [VAH]) levels of vitamin A and examined for the devel-
opment of   Il10  - and   Foxp3  -expressing T cell subsets (  Fig. 6  ).   
By introducing the dietary changes to mothers of preterm 
fetuses, signifi  cant alterations in vitamin A levels generally 
begin to manifest at 6  –  8 wk of age (  41  ). At 6 wk, both dietary 
defi  cient (VAD) and high (VAH) mice had reduced body 
weight compared with control (VAC) mice. In addition, 
although VAH mice grew at approximately the same rate as 
VAC mice, VAD mice began to lose weight at 12 wk of age 
(Fig. S5 A, available at http://www.jem.org/cgi/content/
full/jem.20080950/DC1). All cohorts were killed at 14 wk 
of age and evaluated. There was a signifi  cant reduction in se-
rum retinol levels in mice fed the VAD diet compared with 
those on the VAC diet (Fig. S5 B). No signifi  cant diff  erence 
was found in serum retinol levels of VAH mice relative to 350 DIFFERENTIAL REGULATION OF FOXP3 AND IL-10 BY RETINOIC ACID   | Maynard et al. 
    Figure 3.         at-RA inhibits TGF-      –  mediated induction of IL-10 in CD4 T cells.   (A) Analysis of gut-homing receptor expression on CD4 T cells acti-
vated on CpG-BMDC in the presence of TGF-    . Shaded histograms, isotype control; open histograms, antibody to indicated marker. (B) Naive CD4 T cells 
were stimulated with CpG-BMDC and TGF-     only or TGF-     plus 100 nM at-RA for 3 d before being analyzed for expression of GFP and Thy1.1. (C) Naive JEM VOL. 206, February 16, 2009 
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and in eff  ector sites of the intestinal tissues. In a survey of 
TLR and NOD agonist eff  ects on DCs, it was found that 
activation of the TLR9 pathway most potently promoted 
TGF-      –  mediated induction of the   Il10   gene in naive CD4 T 
cells, in part as a result of its induction of IL-6 and, seemingly, 
its suppression of the synthesis and/or secretion of at-RA 
compared with other TLR and NOD ligands. Accordingly, 
CpG activation of MLN DCs, which normally synthesize 
at-RA and strongly induce T reg cell development, resulted 
in suppressed   Foxp3   induction in favor of enhanced   Il10   
induction. Collectively, these results extend prior studies on 
diff  erential induction of iT reg and Th17 lineages by RA and 
indicate that the balance of at-RA, TGF-    , and the proin-
fl  ammatory mediator IL-6 also diff  erentially regulate devel-
opment of distinct subsets of Foxp3  +   and Foxp3        T reg cells 
from naive CD4 precursors. These fi  ndings add further com-
plexity to our emerging understanding of the diverse path-
ways to IL-10 expression by T cells (  4, 14  ) but indicate that, 
at least initially, induction of   Foxp3   and   Il10   in naive CD4 T 
cells are largely divergent and can be controlled by diff  eren-
tial actions of TLR/NOD ligands on APCs. 
  Although at-RA has been shown to limit development of 
Th17 cells in response to TGF-     and IL-6 (  17  ), the fi  ndings 
herein indicate that although there is signifi  cant overlap in 
the programming of IL-17  –   and IL-10  –  competent cells (e.g., 
requirement for IL-21 by both), the at-RA  –  mediated inhibi-
tion of IL-10 is more sensitive and can be dissociated from 
Th17 development. Thus, although not inconsistent with 
previous studies that have demonstrated overlap between the 
TGF-      –  mediated inductive pathways of IL-10 and IL-17 
(  13, 24  ), we fi  nd that inhibition of at-RA signaling allows 
substantial induction of   Il10   even under conditions that are 
suboptimal for Th17 development. Activation of naive T 
cells in the presence of TGF-     promoted induction of   Il10   
irrespective of the activation state of the APC and the pres-
ence of specifi  c determinants of eff  ector cell diff  erentiation, 
contingent upon limited or absent RAR signaling. Accord-
ingly, DCs that were not activated by TLR or NOD signals 
and did not promote Th17 development potently induced 
IL-10 reporter expression. Under conditions where RAR 
activity was inhibited,   Il10   expression was induced even by 
low levels of IL-6 that were insuffi   cient to promote IL-17 
expression. Naive CD4 T cells can, therefore, develop along 
a Tr1-type program that diverges from Th17 eff  ector cell 
development contingent upon the relative levels of RA, 
TGF-    , and IL-6. The fi  nding that vitamin A defi  ciency 
promotes increased development of   Il10  -expressing T cells in 
VAC mice, as circulating levels of serum retinol typically 
plateau despite high dietary intake and increased tissue stores 
(  41  ). Notably, no evidence of intestinal infl  ammation was 
found in any of the cohorts at the time of termination 
(unpublished data). 
  CD4 T cells isolated from spleen, MLN, Peyer  ’  s patches, 
sLP, and cLP were examined for expression of GFP and Thy1.1 
(  Fig. 6  ). Increased frequencies of Thy1.1  +  Foxp3  +   cells were 
observed in the gut-associated lymphoid tissue (GALT) of 
VAD mice. Conversely, this subset was reduced in both Pey-
er  ’  s patches and the lamina propriae of VAH mice (  Fig. 6, A   
[middle]   and     B  ). Notably, the number of CD4 T cells recov-
ered from the intestinal lamina propriae of VAH mice was 
comparable to that of VAC mice (unpublished data), suggest-
ing that the reduced frequencies of IL-10  –  competent cells in 
these tissues is a result of inhibition of   Il10   induction in the face 
of elevated vitamin A and its metabolite at-RA. 
  The eff  ect of dietary manipulations of vitamin A on the 
induction of   Il10   in Foxp3        cells was quite pronounced. In 
every tissue examined, a signifi  cant increase in the frequency 
of Foxp3       IL-10  +   Tr1-like T cells was found in VAD mice 
compared with VAC mice (  Fig. 6,     A and B   [bottom]). A re-
ciprocal decrease in this population was evident in VAH mice 
relative to VAC mice. Notably, the intensity of Thy1.1 ex-
pression mirrored the eff  ects of vitamin A manipulation on 
frequencies of Thy1.1-expressing T cells. Thus, compared 
with mice on the control diet, the mean fl  uorescence intensi-
ties of Thy1.1 expression by fl  ow cytometric analyses were 
relatively increased or reduced in VAD and VAH mice, re-
spectively (  Fig. 6 A   and not depicted). Collectively, these 
data indicate that reduced dietary vitamin A, which results in 
reduced synthesis of at-RA, promotes elevated induction of 
  Il10   in CD4 T cells. Conversely elevated dietary vitamin A, 
which leads to increased precursor for at-RA, contributes to 
diminished induction of IL-10  –  competent T reg cells in the 
steady state. 
    DISCUSSION   
  In this study, we identify reciprocal eff  ects of the vitamin A 
metabolite at-RA on expression by CD4 T cells of two key 
molecules associated with immune regulation and mucosal 
homeostasis: IL-10 and Foxp3. In contrast to its established 
eff  ects on the induction of Foxp3 and, thus, promotion of iT 
reg cell development (  17  –  20  ), we fi  nd that at-RA potently 
suppresses   Il10   gene expression, primarily at the level of tran-
scription. In support of this, VAD mice developed increased 
frequencies of IL-10  –  competent cells in all lymphoid tissues 
CD4 T cells were stimulated on unactivated or preactivated BMDC alone or in the presence of TGF-     only,  TGF-    plus 100 nM at-RA, or TGF-     plus 1   μ  M 
LE540. On day 5, cells were restimulated for 5 h with D10 BMDC and 1   μ  g/ml OVA peptide in the presence of brefeldin A and analyzed for expression 
of Thy1.1, GFP, and IL-17A. All FACS plots are gated on CD4 T cells and numbers represent the percentages of cells in the respective quadrants. (D) The 
polarized T cell populations were restimulated on day 5 with anti-CD3 and anti-CD28 antibodies for 24 h before the IL-10 content of culture supernatants 
was determined by cytometric bead array. Mean cytokine concentrations   ±   SEM are shown. *, P   <   0.05. All data are representative of at least 
three  experiments.   
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  In accordance with recent studies (  17, 19, 20  ), the 
CD103  +   subset of mucosal DCs was found to be particularly 
effi   cient at inducing Foxp3  +   iT reg cells. However, although 
at-RA  –  producing DCs were enriched in the CD103  +   subset, 
the levels of at-RA produced by CD103        DCs were 
suffi   cient to potently inhibit induction of   Il10   despite more 
limited eff  ects on induction of Foxp3, suggesting exquisite 
sensitivity of the   Il10   gene to repression by RAR signaling. 
Further work will be necessary to better characterize both the 
at-RA  –  producing and   –  nonproducing subsets and to com-
pare their respective roles in mucosal tolerance. However, 
the fi  nding that RA blockade nearly completely abolished 
induction of Foxp3 expression suggests that RA does not just 
enhance but is a critical cofactor for TGF-      –  mediated Foxp3 
iT reg cell development. 
  Given that splenic DCs are defi  cient in the enzymatic 
pathway for conversion of vitamin A to RA, the observed 
inhibition of Foxp3 induction by splenic DCs plus TGF-     
in the presence of RAR blockade (  Fig. 5 B  ) raised the pos-
sibility that in our and some previous studies, an unappreci-
ated amount of at-RA activity might have been derived from 
the culture medium. Indeed, we have found suffi   cient at-RA 
present in many lots of fetal bovine serum that is adequate to 
induce high expression of Foxp3 under APC-free conditions 
vivo supports the role of at-RA in suppressing development 
of IL-10  –  competent T cells, particularly the Foxp3        IL-10  –
  competent Tr1-type subset. The relative frequencies of Foxp3  +   
and Foxp3        T reg cells are therefore regulated at least in part 
by dietary intake of vitamin A. 
  Other variables are also likely to aff  ect the relationship of 
developing IL-10  –  competent T cells as a subset of eff  ector 
lineages (such as Th17) or as an independent pathway. Prior 
studies of Tr1 cell development showed eff  ects of IL-10 itself, 
corticosteroids, and vitamin D3 as determinants promoting 
IL-10 expression (  4, 5, 14  ). Furthermore, it is not unlikely 
that developing intestinal Th17 cells might extinguish ex-
pression of the   Il17a/Il17f   cytokine locus late in the infl  am-
matory response and give rise to IL-10  –  competent cells that 
lack Th17 eff  ector cytokines, which is analogous to   infectious 
settings wherein chronic antigenic persistence promotes the 
emergence of IL-10 expression from eff  ector T cell responses. 
Accordingly, we have found modest increases in the frequen-
cies of Th17 eff  ectors in the GALT of VAD mice, as well as 
a fraction of cells that coexpress IL-17A and high levels of the 
Thy1.1 reporter (unpublished data). These fi  ndings highlight 
the overlapping development of IL-10 competency under 
conditions of diminished RA availability, whether through 
Th17-associated or -independent pathways. 
    Figure 4.         RA inhibits transcription but not translation of IL-10.   (A and B) CD4 T cells differentiated as described in   Fig. 3 C   were reactivated for 24 h 
with anti-CD3 and anti-CD28 antibodies, and IL-10 (A) and IL-21 (B) production was quantifi  ed by cytometric bead array. (C) On day 5 after activation, CD4 T 
cells differentiated in the presence of CpG-activated BMDC plus the additives indicated were harvested for analysis of   Il10   mRNA by real-time PCR. Data are 
normalized to cells activated with CpG-activated BMDC and antigen only and are from one of two experiments with similar results. (D) CD4  + Thy1.1 +   cells 
were isolated from naive 10BiT mice as shown (top left) and left unstimulated or stimulated for 24 h with anti-CD3 and anti-CD28 antibodies only or with the 
addition of 100 nM at-RA or 1   μ  M LE540 before IL-10 protein in supernatants was quantifi  ed by cytometric bead array. Mean cytokine concentrations   ±  SEM 
are shown in A, B, and D, and all data are representative of three independent experiments. **, P   <   0.005.    JEM VOL. 206, February 16, 2009 
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  The fi  nding that TLR9 had the greatest effi   cacy in its recip-
rocal eff  ects on expression of the   Foxp3    gfp   and 10BiT reporters is 
consistent with a recent study demonstrating that Foxp3  +   cells 
are increased in small intestinal tissues of   Tlr9        /      mice at steady 
state. Hall et al. (  43  ) found corresponding decreases in IL-17  –   
and IFN-      –  expressing eff  ector T cells, as well as more modest 
decreases in IL-10  –  expressing cells, at steady-state in   Tlr9        /      
mice. Furthermore, CpG or DNA of the commensal bacteria 
markedly inhibited Foxp3  +   iT reg cell development induced by 
DCs isolated from the intestinal lamina propria. Those data and 
data herein are consistent with in vivo modulation of at-RA 
of activation of naive CD4 T cells by addition of TGF-     
alone, as indicated by nearly complete inhibition of Foxp3 
expression by addition of RARi (Fig. S6, available at http://
www.jem.org/cgi/content/full/jem.20080950/DC1), as well 
as direct quantitation of at-RA (  42  ) (unpublished data). 
Notably, in contrast to cultures with BM- or tissue-derived 
DCs supplemented with TGF-    , at-RA blockade under 
APC-free conditions did not result in expression of   Il10  , 
which is consistent with the requirement for at least low 
levels of IL-6 for induction of   Il10   under conditions of RAR 
suppression (Fig. S6). 
    Figure 5.         Mucosal DC-derived RA inhibits the induction of IL-10 in CD4 T cells  . (A) 5   ×   10  5   naive  10BiT. Foxp3  gfp  .OT-II CD4 T cells were stimulated 
with 1   μ  g/ml OVA peptide and 10  5   CD11c +   DC from the spleen, MLN, sLP, or cLP in the absence (top) or presence (bottom) of 5 ng/ml TGF-    1. (B) CD4 T cells 
were stimulated with splenic or MLN DC as described in A in the presence of 100   μ  M TGF-    1 and RA or 1   μ  M LE540. CpG-act are DC that were preactivated 
for 16 h with CpG and then washed and cocultured with CD4 T cells in the presence of OVA peptide and TGF-    1. (C) CD11c  +   MLN DC were FACS sorted into 
CD103        and CD103  +   fractions before being used in cocultures with T cells as in A. Data are representative of three to four independent experiments.    354 DIFFERENTIAL REGULATION OF FOXP3 AND IL-10 BY RETINOIC ACID   | Maynard et al. 
cells. Because expression of IL-10 was not examined in that 
study, it is unknown whether similar bacterial species-specifi  c 
eff  ects regulate the balance of Foxp3 and IL-10 competent T reg 
cell subsets and whether there is overlap or segregation of bacte-
rial species that might induce IL-17  –   and IL-10  –  expressing cells 
in the GALT. 
levels in the GALT by TLR9 agonists derived from the intestinal 
microbiota as a major mechanism by which the balance of T reg 
cell subsets is achieved. Ivanov et al. (  44  ) found reciprocal induc-
tion of Th17 cells and Foxp3  +   T reg cells in the GALT by spe-
cifi  c commensal bacteria, identifying a role for some but not all 
bacterial species in regulating the balance of T reg cells and Th17 
    Figure 6.         Reduced dietary vitamin A enhances and increased dietary vitamin A inhibits the induction of   Il10   in vivo in the steady state.   
(A) Male 10BiT.  Foxp3  gfp  mice that were exposed to vitamin A  –  modifi  ed diets as described were killed at 12  –  14 wk of age. Single cell suspensions were pre-
pared from the indicated tissues, and expression of GFP and Thy1.1 by CD4 T cells was determined by FACS. Plots are gated on CD4 T cells and numbers repre-
sent the percentage of CD4 T cells in quadrants 1, 2, and 4. (B) Graphical summary of data represented in A to denote the frequency of   Il10 -Thy1.1 – expressing 
cells among Foxp3        (bottom) and Foxp3  +   (middle) cells in the respective tissue sites among the three diet groups. Graphs show mean frequencies   ±  SEM 
and all data are pooled from 8  –  12 mice per diet group. *, P   <   0.05; **, P   <   0.005; ***, P   <   0.001. Data are representative of three independent experiments.    JEM VOL. 206, February 16, 2009 
ARTICLE
355
CD4 T cells, this suggests that mature T reg cells are resistant 
to inhibitory eff  ects of at-RA on   Il10   induction, respond 
to at-RA diff  erently from naive T cells, and/or interact pref-
erentially with a subset of APCs that lack the RA biosyn-
thetic pathway. 
  Further studies defi  ning the inductive pathways to   Il10   
gene expression will be needed to understand how RAR sig-
naling might impact   Il10   suppression in early versus late CD4 
lineage development. Notably, however, in unpublished 
studies of 10BiT.  Foxp3    gfp   mice, we have found that both 
Foxp3  +   and Foxp3        subsets of Thy1.1 reporter-positive (IL-
10 competent) T cells are highly enriched for expression of 
the gene   Prdm1  , which encodes the transcription factor B 
lymphocyte  –  induced maturation protein-1 (Blimp-1). Martins 
et al. (  47  ) reported that CD4 T cells with targeted ablation of 
Blimp-1 showed reduced expression of IL-10 and developed 
spontaneous colitis, implicating this factor as a critical inducer 
of IL-10 in T cells. Importantly, expression of Blimp-1 in 
B cells is induced by STAT3-dependent signaling, particu-
larly that activated by IL-6, IL-21, and IL-10 (  48  ). Although 
similar induction of Blimp-1 by these same factors in CD4 T 
cells has not yet been reported, we speculate that the induc-
tion of   Il10   transcription and, by extension, repression of   Il10   
transcription by at-RA results from interplay of these same 
signaling pathways, which converge on the expression of 
Blimp-1 to control  Il10   transcription. Implementation of 10BiT.
  Foxp3    gfp   mice to directly test these and other pathways to co-
ordinate and diff  erential expression of   Il10   and   Foxp3   should 
be informative. 
  MATERIALS AND METHODS 
  Mice.     C57BL/6 (B6), C57BL/6.Ly5.1 (CD45.1), and C57BL/6.  Icosl        /      mice 
were purchased from The Jackson Laboratory. C57BL/6.  Myd88        /      mice 
were provided by D. Chaplin and S. Michalek (University of Alabama at Bir-
mingham, Birmingham AL). 10BiT.  Foxp3    gfp   mice have been described previ-
ously (  8  ). All mice were bred and maintained and all animal experimentation 
was approved in accordance with guidelines and approval of the University of 
Alabama at Birmingham Institutional Animal Care and Use Committee. 
  Antibodies and reagents.     PE-conjugated anti-CD44 (IM7), anti-      4        7   
(LPAM), anti-CD90.1 (OX-7), anti-CD103 (M290), anti-IL-17 (TC11-
18H10), PerCP (peridinin chlorophyll-a protein)-conjugated anti-CD90.1 
(OX-7), and functional grade anti-IL-10R (1b1.3a) were purchased from BD; 
allophycocyanin-conjugated anti-CD4 (GK1.5), anti-IL-10 (JES5-16S3), 
anti  –  IFN-     (XMG1.2), PE-conjugated and anti  –  IL-10 (JES5-16S3), PE-
Cy7  –  conjugated anti-CD4 (GK1.5), affi   nity-purifi  ed anti-CCR9 (CW-1.2), 
and functional grade anti  –  IL-6 (MP5-20F3) were purchased from eBiosci-
ence. The following reagents were purchased from R  &  D Systems: recombi-
nant human TGF-    1, IL-21 R/Fc chimera, WSSX-1 R/Fc chimera, and 
anti  –  IFN-    /    R1. at-RA was purchased from Sigma-Aldrich and the RA 
inhibitor LE540 was purchased from Wako Chemicals USA, Inc. MDP, LTA, 
poly (I:C), LPS, and CpG ODN were purchased from InvivoGen. 
  Diff   erentiation and activation of BMDCs.     BMDC were prepared 
according the protocol described by Lutz et al. (  49  ) with slight modifi  cations. 
In brief, BM cells were plated in 6-well plates at a density of 5   ×   10  5  /ml in 
RPMI 1640 medium containing 10% FCS, 100 IU/ml penicillin, 100   μ  g/ml 
streptomycin, nonessential amino acids, 1   μ  M sodium pyruvate, 2.5   μ  M     -
mercaptoethanol, and 2   μ  M   l  -glutamine (R-10 medium) with 2% GM-CSF 
supernatant for 10 d. On day 10, BMDCs were left unstimulated or were 
  Vitamin A or at-RA has been reported to inhibit de-
velopment of IFN-      –   and IL-17  –  producing CD4 T cells 
(  17, 23, 45  ), and RA has been reported to enhance induction 
of IL-4 production by Th2 cells (  45  ), possibly as a result of 
RA-mediated suppression of IL-10. Conversely, factors that 
promote Th1, Th2, and Th17 development have been shown 
to limit Foxp3  +   T reg cell development (  30, 46  ). In contrast, 
it is now clear that IL-10 can be induced in association with 
all CD4 T cells subsets, regulatory and eff  ector (  14  ). This 
likely represents a strategic adaptation to allow T cell  –  medi-
ated immune regulation at eff  ector sites where the proinfl  am-
matory millieu would be antagonistic to Foxp3 expression. 
In this context, it is notable that the characteristics of the 
10BiT reporter model, which sensitively identifi  es cells in 
which the   Il10   gene has become transcriptionally active, has 
identifi  ed a remarkable degree of posttranscriptional regula-
tion of IL-10 protein production, such that many reporter-
positive cells induced by TGF-    and IL-6 under RA-defi  cient 
conditions require additional signals to produce high amounts 
of IL-10, despite high levels of   Il10   transcripts both in Th17-
associated and Tr1-type cells (unpublished data). This implies 
a mechanism akin to that recently reported for NK cells (  33  ), 
whereby derepression of blocks on translation of   Il10   mRNA 
transcripts represents a principal strategy by which expression 
of IL-10 is primed but not fully executed until late in CD4 T 
cell development, whether in association with eff  ector or 
regulatory lineages. 
  Considering the nonredundant role for T cell  –  derived 
IL-10 in maintaining intestinal immune homeostasis and the 
marked predominance of IL-10  –  competent T cells in the in-
testinal tissues, it is not immediately clear why at-RA, which 
is prevalent in the intestines and associated lymphoid tissues, 
would be inhibitory to   Il10   expression by naive CD4 T cells. 
This is particularly intriguing given the fact that the majority 
of Foxp3  +   CD4 T cells in the intestines are competent for 
IL-10 expression, especially in the colon (  8  ). Notably, how-
ever, the intestines are also enriched for IL-10  –  competent T 
cells that lack Foxp3 (  8  ), a population which is increased by 
VAD, which is consistent with their development via an 
RA-independent pathway. Although a fraction of Foxp3        
IL-10  –  competent cells coexpress eff  ector cytokines, particu-
larly IFN-     and IL-17, the large majority do not, suggesting 
that development of Tr1-like cells in the intestines arise inde-
pendently of eff  ector lineage development, extinguish eff  ec-
tor cytokines caused by chronic reactivity to the commensal 
microbiota, or both (  8, 14  ). 
  Concerning T cells that coexpress   Foxp3   and   Il10  , al-
though rapid induction of this phenotype was observed in a 
minor fraction of naive CD4 T cells activated with TGF-     
and IL-6 under conditions of limited at-RA in vitro, we have 
previously shown that Foxp3  +  IL-10  +   T reg cells arise in the 
periphery from Foxp3  +  IL-10        precursors, especially in intes-
tinal tissues (  8  ). Thus, mechanisms yet to be defi  ned must 
exist for induction of   Il10   transcription in committed Foxp3  +   
T reg cells, i.e., late in the T reg cell development. Given the 
potent inhibitory eff  ects of at-RA on   Il10   induction in naive 356 DIFFERENTIAL REGULATION OF FOXP3 AND IL-10 BY RETINOIC ACID   | Maynard et al. 
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